Annual Working Capital
$22.66 M
+$22.30 M+6193.89%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual working capital is $22.66 million, with the most recent change of +$22.30 million (+6193.89%) on December 31, 2023.
- During the last 3 years, AQST annual working capital has fallen by -$863.00 thousand (-3.67%).
- AQST annual working capital is now -54.46% below its all-time high of $49.76 million, reached on December 31, 2019.
Performance
AQST Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$81.42 M
-$8.70 M-9.65%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly working capital is $81.42 million, with the most recent change of -$8.70 million (-9.65%) on September 30, 2024.
- Over the past year, AQST quarterly working capital has increased by +$63.02 million (+342.49%).
- AQST quarterly working capital is now -14.59% below its all-time high of $95.32 million, reached on March 31, 2024.
Performance
AQST Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AQST Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6193.9% | +342.5% |
| 3 y3 years | -3.7% | +342.5% |
| 5 y5 years | -45.1% | +342.5% |
AQST Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | +6193.9% | -14.6% | >+9999.0% |
| 5 y | 5-year | -54.5% | +6193.9% | -14.6% | >+9999.0% |
| alltime | all time | -54.5% | +6193.9% | -14.6% | >+9999.0% |
Aquestive Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $81.42 M(-9.7%) |
| Jun 2024 | - | $90.12 M(-5.5%) |
| Mar 2024 | - | $95.32 M(+320.7%) |
| Dec 2023 | $22.66 M(+6193.9%) | $22.66 M(+23.1%) |
| Sep 2023 | - | $18.40 M(+1521.1%) |
| Jun 2023 | - | $1.14 M(-65.8%) |
| Mar 2023 | - | $3.32 M(+823.1%) |
| Dec 2022 | $360.00 K(-98.6%) | $360.00 K(-76.4%) |
| Sep 2022 | - | $1.53 M(-89.0%) |
| Jun 2022 | - | $13.87 M(-24.6%) |
| Mar 2022 | - | $18.40 M(-27.3%) |
| Dec 2021 | $25.30 M | $25.30 M(+0.5%) |
| Sep 2021 | - | $25.17 M(-10.0%) |
| Jun 2021 | - | $27.96 M(+14.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $24.39 M(+3.7%) |
| Dec 2020 | $23.52 M(-52.7%) | $23.52 M(+76.7%) |
| Sep 2020 | - | $13.31 M(-54.1%) |
| Jun 2020 | - | $29.03 M(-18.8%) |
| Mar 2020 | - | $35.73 M(-28.2%) |
| Dec 2019 | $49.76 M(+20.6%) | $49.76 M(+176.3%) |
| Sep 2019 | - | $18.01 M(+24.7%) |
| Jun 2019 | - | $14.44 M(-45.2%) |
| Mar 2019 | - | $26.32 M(-36.2%) |
| Dec 2018 | $41.25 M(+221.9%) | $41.25 M(-26.4%) |
| Sep 2018 | - | $56.03 M(+1664.7%) |
| Jun 2018 | - | $3.17 M(-54.3%) |
| Mar 2018 | - | $6.95 M(-45.8%) |
| Dec 2017 | $12.81 M(+2.3%) | $12.81 M |
| Dec 2016 | $12.53 M | - |
FAQ
- What is Aquestive Therapeutics annual working capital?
- What is the all time high annual working capital for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual working capital year-on-year change?
- What is Aquestive Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly working capital year-on-year change?
What is Aquestive Therapeutics annual working capital?
The current annual working capital of AQST is $22.66 M
What is the all time high annual working capital for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual working capital is $49.76 M
What is Aquestive Therapeutics annual working capital year-on-year change?
Over the past year, AQST annual working capital has changed by +$22.30 M (+6193.89%)
What is Aquestive Therapeutics quarterly working capital?
The current quarterly working capital of AQST is $81.42 M
What is the all time high quarterly working capital for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly working capital is $95.32 M
What is Aquestive Therapeutics quarterly working capital year-on-year change?
Over the past year, AQST quarterly working capital has changed by +$63.02 M (+342.49%)